Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Dec;331(4):334-40.
doi: 10.1007/BF00500815.

A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist

A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist

S Patel et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec.

Abstract

Lesioning and 2-deoxyglucose (2-DG) autoradiographic studies were applied to the hyperactivity induced in rats by intra-accumbens treatment with the dopamine agonist 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydro-naphthalene (ADTN). Lesions made in substantia innominata and rostro-ventral globus pallidus both attenuated the hyperactivity although no consistent changes in 2-DG uptake were recorded in these areas. Compared to normal rats, hyperactive rats showed greatly increased glucose utilization in the subthalamic nucleus and lateral habenula. Lesioning the subthalamic nucleus greatly reduced the hyperactivity, whereas a lateral habenula lesion was ineffective. Hyperactivity was associated with a discrete, bilateral area of increased 2-DG uptake in the reticular formation which corresponded to the description of the deep mesencephalic nucleus (DMN). Lesions made in the DMN greatly attenuated the hyperactivity response. The DMN may be a locomotor region in the rat.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 1984 Apr 23;298(1):191-2 - PubMed
    1. J Comp Neurol. 1980 Mar 15;190(2):245-58 - PubMed
    1. Brain Res. 1979 Nov 16;177(2):325-36 - PubMed
    1. Brain Res. 1983 Apr 18;265(2):249-57 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(3):201-6 - PubMed